The male god of magic capital

Chengtian Holdings, in the trading room.

Luo Cheng was a little excited, everyone's opening of the position went smoothly this time, and he directly invested 100 billion in it, successfully blocked the opening of the Eastern Fund, and bought 1 million shares, which was very smooth.

Li Zongchao of Fenghua Group told Luo Cheng before that Oriental Fortune Group intends to participate in the daily operation of Zhifei Biology, so it will buy a large number of stocks, and the sharp drop in the stock market made Chengtian Private Equity Fund sell ahead of time. The moment to act.

At that time, the stock price fell at an accelerated rate. It must be that Dongfang Fund smashed the stock price and wanted more investors to sell the stock. As a result, all the selling orders were eaten up by Chengtian Private Equity Fund, and the stock price of Zhifei Biological Company was pulled to 110. Yuan per share, now it's fun.

You must know that the stock market began to plummet today, and the stocks in the medical sector basically followed suit. Only the stock price of Zhifei Biotech is a wonderful flower, and it has risen against the trend. Obviously, there are big funds optimistic about the future of Zhifei Biotech. prospects, or large institutions have selected Zhifei Biotech for their positions.

Many retail investors who were not firm in their will, or institutional traders who were not optimistic about the follow-up stock market, or fund managers who planned to adjust their positions and sell Zhifei Biostock, saw that Zhifei Biotech went against the trend and rose at this moment. The Zhifei Biological stock on the Internet must be covered up.

The comments below Zhifei Biological Company are lively.

"Damn it, brothers, the stock price of Zhifei Biology is too strong today, and it has bucked the trend and soared!"

"Other medical giants, such as Pien Tze Huang, Aier Ophthalmology, Fuxing Medicine, WuXi AppTec, Mindray Medical, and Hengrui Medicine are all falling, but it is the only one that stands out. Don't you find it very strange?"

"There is a large amount of money to buy the bottom. I guess it may be Dongfang Fund. Before that, Dongfang Fund has been buying Zhifei Biotech. As a result, the stock market plummeted. The stock price of Zhifei Biology dropped from 190 yuan per share to a minimum of 90 yuan per share. It was cut in half, and Dongfang Fund must have seen the opportunity and bought a lot of money at a low price, which is why the stock price of Zhifei Biotech has bucked the trend and soared today!"

"It must be, Geng Shizhong, the star manager of Dongfang Fund, is increasing his holdings of Zhifei Biology!"

"I heard that the Oriental Fortune Group is going to set foot in the medical industry. I don't know if it's true. Can these people who play finance be able to do a good job in the medical real industry?"

"Because of the continuous financing and continuous mergers and acquisitions during the development period, the founder team of Zhifei Biotech has a very low shareholding ratio, and the shares are all held by large institutions."

"In fact, many large institutions hold the stocks of large-scale listed companies, and by competing for the right to speak, they realize the transfer of interests, or some kind of ulterior interest exchange."

"I heard that Zhifei Biological Company is discussing whether to cooperate with a medical giant in the United States. The Oriental Fortune Group may want to increase its voice and facilitate this cooperation."

"Hey, this AC-Hib unique to Zhifei Biotech, many companies want to cooperate with it. Is that American medical company called Amgen?"

"Brother, you are right. I am an employee of Zhifei Biotech. Amgen Corporation of the United States approached us and proposed cooperation, but Zhifei Biotech's major shareholder objected, and the representatives of Dongcai Fortune Group strongly opposed it. Facilitated the cooperation between Zhifei Bio and Amgen, and now the board of directors is stalemate!"

"Hoohoo, no wonder Dongfang Fund is crazy about buying. It turns out that it is to increase the right to speak on the board of directors and promote the cooperation between Zhifei Biologics and Amgen, so that Amgen can get AC- Hib!"

"Damn, this American company, Amgen, really has a good plan!"

"The boss of the Oriental Fortune Group has a good relationship with the people of Amgen, right?"

"I'll go. Tomorrow, the Orient Fund will probably be sweeping the market!"

····
But at this moment, Geng Shizhong of Dongfang Fund looked at the comment area under Zhifei Biology, and couldn't express his inner pain.

He planned to buy a large sum of shares of Zhifei Biological Company today, but Chengtian Private Equity Fund jumped out and swept the selling orders in the market, eating up everything, which made the stock price of Zhifei Biological Company soar against the trend 7 yuan, to 110 yuan per share.

Well now, everyone thinks that the stock price of Zhifei Biotech is very stable and has a very good prospect, so they are unwilling to sell the stock. How can Orient Fund attract money?

Moreover, the stock price is still at 110 yuan per share, which increases the cost of building a warehouse.

But thinking that Zhifei Biological Company will hold a board meeting next time, he must buy Zhifei Biological Company's stock at 110 yuan per share tomorrow.

"Hey, it's all to blame for the devil's financial god, who actually swept the goods in front of me and snatched the bargaining chips that originally belonged to Dongfang Fund."

"It's really hateful!"

Today's good fund-raising plan was directly destroyed by the financial god of Shanghai.

In particular, Chengtian Private Equity Fund has swept so many selling orders, causing the stock price to rise against the trend. Investors in the market will not easily sell the stocks they hold in the future.

If the Orient Fund wants to absorb enough chips, it has to raise the stock price. However, the funds that the Orient Fund can use now are not much, and most of them are stock assets.

If there are very few selling orders in the market, if large-scale positions are built, the stock price will rise a lot. At that time, it will be a wedding dress for Chengtian Private Equity Fund for nothing.

Moreover, the liquidity of Orient Fund is limited, and it is impossible to buy Zhifei Biology without thinking, regardless of the cost, which is not cost-effective at all.

"Manager, should we call the God of Finance in Modu directly and ask him to sell us the market price of the stock in his hand?"

Geng Shizhong immediately said: "Contact the God of Finance in Shanghai immediately, I want to buy all the stocks of Zhifei Bio in their hands at the market price!"

"Yes, manager!" The assistant immediately called the people of Chengtian Holdings, but was rejected!
"Bastard!!!" Geng Shizhong was furious, like a raging lion.

This male god of finance in the devil's city blocked their Dongfang Fund. Now that he has made money, he still refuses to sell it. He is simply greedy!

He had no choice but to scan the goods on the secondary market tomorrow.

The next day, May 5th, Friday, when the stock market opened, Geng Shizhong was sweeping the secondary stock market, buying Zhifei Biology continuously, and of course he would also drop it to buy more stocks, and the stock market is a whole day long. It fell, and the stock price of Zhifei Biological Company continued to rise against the trend!

This is two consecutive days of rising against the trend, which is simply wonderful!

Investors who eat melons were stunned.

"I'll go, this Oriental Fund is indeed sweeping goods!"

"Oriental Fund is buying a lot of money, I will not sell stocks, and wait for the stock price to continue to rise!"

"I'm going, isn't this Oriental Fund crazy?"

"Aha, I'm long Zhifei creatures, I'll withdraw after earning 2 points!"

"This Orient Fund is too aggressive in sweeping goods, it's awesome!"

"I'm waiting for the stock price to skyrocket to a higher position before selling!"

"It would be nice if the stock price returned to 190 yuan per share, haha!"

···
Geng Shizhong is really suffering and can't tell, let's continue to scan the secondary stock market!
·
Sina Finance: Today, the market failed to reverse its decline and continued to fall. Most of the concept sectors fell, and there was a strong wait-and-see mood for funds.The combined turnover of the Shanghai and Shenzhen stock markets only exceeded 9000 billion yuan, shrinking again from the previous day.

As of the close, the three major stock indexes fell across the board

Most of the A-share stocks are down, and the stock price of Zhifei Biological Company is once again thriving!

"Oriental Fund is fierce!"

"This time, Zhifei Biological Company will cooperate with Amgen Company of the United States, which will benefit Amgen Company a lot. I have to buy more US stocks!"

"It's really unreasonable for Dongfang Fund to sweep goods!"

"The Orient Fund has absorbed a lot of chips in the secondary market, which can facilitate the cooperation between Zhifei Biological Company and Amgen Company of the United States."

·
At this moment, in Shenzhen City, a Tianhai International Hotel.

Wu Tianhai of Tianhai Group, Dong Yunqi of Oriental Fortune Group, and Davis, the Asia-Pacific president of Amgen, gathered together for tea.

"Brother Dong, is the cooperation between Zhifei Biological Company and American Amgen Company stable this time?"

Wu Tianhai looked at Zhifei Biology's comment section, and said with a smile, "Your Orient Fund has been really aggressive in sweeping up the stock, and it has pushed up the stock price so much."

Dong Yunqi smiled and said: "Actually, the price of opening a warehouse is still high, and I don't know what Geng Shizhong did, but it's okay."

Davis, the Asia-Pacific President of Amgen, said: "Mr. Wu, Mr. Dong, we have a happy cooperation!"

The biological product of Zhifei Biology, meningococcal group AC (conjugated) Haemophilus influenzae type b (conjugated) combined vaccine, referred to as AC-Hib triple vaccine, is very much needed by Amgen in the United States. This cooperation will give Amgen Corporation of the United States brings a lot of benefits.

···
Chengtian Holding Company, Luo Cheng watched Zhifei Biological Company's stock price soar to 120 yuan per share, and he was very happy.

This Chengtian Private Equity Fund holds 6.25% of the equity of Zhifei Bio, 1 million, and now has a floating profit of 20 billion, worth 120 billion.

This investment will be held for a long time.

He opened the mouth and said: "I will hold these 1 million shares for the rest of my life. Don't sell them. If the Orient Fund calls, I will directly refuse!"

"Yes, BOSS!"

In the evening, Li Zongchao of Fenghua Group invited Luo Cheng to have dinner at the Shangri-La Hotel.

"Mr. Luo, the board meeting is about to be held. Your Chengtian Private Equity Fund holds 6.25% of the equity of Zhifei Biological Company, and our Fenghua Group holds 7% of the equity, plus Fuxing Group's 3%. Our side holds The 16.25% stake, together with the other shareholders I have recruited, can prevent the people from the Eastern Fortune Group from making Zhifei Biologics to cooperate with Amgen Corporation of the United States!"

Luo Cheng said with a smile: "Amgen of the United States has cooperation with Shenzhou Baekje, Tianhai Group, Nuoan Group, and Jardine Group. They want to obtain the unique AC-Hib of Zhifei Biological Company. Naturally, I want blocked."

Li Zongchao said with a smile: "Haha, it is impossible for American Amgen to cooperate with Zhifei Biological Company."

Soon, on Saturday, at the board meeting of Zhifei Biological Company, the two sides had a heated discussion on the cooperation between Zhifei Biological Company and American Amgen Company.

Because the representatives of Chengtian Holdings also objected, the cooperation was rejected in the end.

The cooperation between American Amgen and Zhifei Biotech failed!

Wu Tianhai, Dong Yunqi, and Davis were suddenly furious.

In particular, Dong Yunqi was very annoyed when he learned that Chengtian Private Equity Fund prevented Dongfang Fund from opening a position.

This made him lose face in front of Wu Tianhai and Davis.

Wu Tianhai: "Brother Dong, this little bastard Luo Cheng has a very bad heart, is very vicious, and is very insidious. Before, he forced the girl I liked to death. I have long been at odds with him. If you want to mess with him, remember to call me! "

During this period of time, Wu Tianhai and Luo Cheng fought back and forth, sometimes taking advantage and sometimes suffering losses, but in short, they didn't get any benefits, but it was true that they made the subsidiaries of Chengtian Holdings very embarrassed, but they didn't go bankrupt collapse.

Dong Yunqi smiled lightly, and didn't say anything. To him, this was not a big deal, it was just losing face in front of Wu Tianhai and Davis.

This devil's financial god has a bad relationship with the members of their Bund Trading Club, but he doesn't have much conflict with the Oriental Fortune Group. He regards the devil's financial god as a junior.

This time Chengtian Holdings got involved with Fenghua Group, which made him feel disgusted in his heart.